This independent HPLC lab test confirms GLP3-R (Retatrutide) 50mg from Licensed Peptides at 99.790% purity. The analysis was conducted by Janoshik Labs on October 9, 2025. The tested quantity of 54.93mg exceeds the stated label claim of 50mg, demonstrating consistent formulation and manufacturing accuracy.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for metabolic regulation, weight management, and glycemic control. A purity level of 99.790% indicates high-grade synthesis with minimal contamination. The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.